Abstract
In designing functional assays for the various classes of hematopoietic cells described in this book, one needs to consider the properties of the cell to be measured which must be incorporated into the assay design, and the end points to allow its specific detection. The most primitive hematopoietic stem cells (HSC) in mouse and man are characterized by two cardinal properties that distinguish them from more mature clonogenic cells and their terminally differentiated progeny. Firstly, HSCs are pluripotent: they are characterized by the potential to differentiate into all of the eight major lineages of lymphoid, myeloid, and erythroid cells in vivo (1–3). Secondly, HSCs are able to self-renew, or generate daughter stem cells in vivo and in vitro that are functionally identical to the stem cell that gave rise to them (3–5). These hallmark properties of HSCs are measured empirically by their potential to regenerate and maintain lymphocytes, granulocytes, and erythrocytes upon transplantation into lethally irradiated or immunocompromised primary and secondary hosts. However, functional assays for primitive HSCs must also consider the fact that differentiated cells present in the hematopoietic organs at different times after bone marrow transplantation are derived from different types of precursors (6), and particularly at later times, cannot be assumed to be of donor origin (7). Support for this concept derives from the relatively recent demonstration in mice that most, if not all, spleen colonies detectable ≈ 2 wk after transplantation originate
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramson, S., Miller, R.G., and Phillips, R.A. (1977) The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J. Exp. Med. 145, 1567–1579.
Jordan, C. T. and Lemischka, I. R. (1990) Clonal and systemic analysis of longterm hematopoiesis in the mouse. Genes Dev. 4, 220–232.
Szilvassy, S. J. and Cory, S. (1994) Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 84, 74–83.
Fraser, C. C., Eaves, C. J., Szilvassy, S. J., and Humphries, R. K. (1990) Expansion in vitro of retrovirally marked totipotent hematopoietic stem cells. Blood 76, 1071–1076.
Miller, C. L. and Eaves, C. J. (1997) Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. 13,648 –13.65
Magli, M. C., Iscove, N. N., and Odartchenko, N. (1982) Transient nature of early haematopoietic spleen colonies. Nature 295, 527–529.
Jones, R. J., Celano, P., Sharkis, S. J., and Sensenbrenner, L. L. (1989) Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 73, 397–401.
Till, J. E. and McCulloch, E. A. (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213–222.
Ploemacher, R. E. and Brons, R. H. C. (1989) Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell. Exp. Hematol. 17, 263–266.
Jones, R. J., Wagner, J. E., Celano, P., Zicha, M. S., and Sharkis, S. J. (1990) Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 347, 188–189.
McCulloch, E. A. and Till, J. E. (1960) The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiat. Res. 13, 115–125.
Hodgson, G. S., Bradley, T. R., and Radley, J.M. (1982) The organization of hemopoietic tissue as inferred from the effects of 5-fluorouracil. Exp. Hematol. 10, 26–35.
Szilvassy, S. J., Humphries, R. K., Lansdorp, P. M., Eaves, A.C., and Eaves, C. J. (1990) Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. USA 87, 8736–8740.
Harrison, D. E., Astle, C. M., and Delaittre, J. A. (1978) Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging. J. Exp. Med. 147, 1526–1531.
Harrison, D. E., Jordan, C. T., Zhong, R. K., and Astle, C. M. (1993) Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp. Hematol. 21, 206–219.
Harrison, D. E. and Astle, C. M. (1982) Loss of stem cell repopulating ability upon transplantation: effects of donor age, cell number, and transplantation procedure. J. Exp. Med. 156, 1767–1779.
Szilvassy, S. J., Fraser, C. C., Eaves, C. J., Lansdorp, P. M., Eaves, A. C., and Humphries, R. K. (1989) Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc. Natl. Acad. Sci. USA 86, 8798–8802.
Boggs, D. R., Boggs, S. S., Saxe, D. F., Gress, L. A., and Canfield D. R. (1982) Hematopoietic stem cells with high proliferative potential. Assay of their concentration in marrow by the frequency and duration of cure of W/Wν mice. J. Clin. Investig. 70, 242–253.
Taswell, C. (1980) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126, 1614–1619.
Lamar, E. E. and Palmer, E. (1984) Y-encoded, species-specific DNA in mice: evidence that the Y chromosome exists in two polymorphic forms in inbred strains. Cell 37, 171–177.
Spangrude, G. J., Heimfeld, S., and Weissman, I. L. (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241, 58–62.
Szilvassy, S. J. and Cory, S. (1993) Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood 81, 2310–2320.
Eppig, J. J., Kozak, L. P., Eicher, E. M., and Stevens, L. C. (1977) Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature 269, 517–518.
Harrison, D. E., Astle, C. M., and Lerner, C. (1988) Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells. Proc. Natl. Acad. Sci. USA 85, 822–826.
Conneally, E., Cashman, J., Petzer, A., and Eaves, C. (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 94, 9836–9841.
Wang, J. C. Y., Doedens, M., and Dick, J. E. (1997) Primitive human hematopoeitic cells are enriched in cord blood compared to adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell (SRC) assay. Blood 89, 3919–3925.
Holyoake, T. L., Nicolini, F. E., and Eaves, C. J. (1999) Functional differences between transplantable human hematopoeitic stem cells from fetal liver, cord blood and adult marrow. Exp. Hematol. 27, 1418–1427.
Zanjani, E. D., Flake, A. W., Rice, H., Hedrick, M., and Tavassoli, M. (1994) Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J. Clin. Investig. 93, 1051–1055.
Kamel-Reid, S. and Dick, J. E. (1988) Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242, 1706–1709.
Pflumio, F., Izac, B., Katz, A., Shultz, L. D., Vainchenker, W., and Coulombel, L. (1996) Phenotype and function of human hematopoietic cells engrafting immunedeficient CB17-severe combined immunodeficiency mice and nonobese diabeticsevere combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88, 3731–3740.
Nolta, J. A., Dao, M. A., Wells, S., Smogorzewska, E. M., and Kohn, D. B. (1996) Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc. Natl. Acad. Sci. USA 93, 2414–2419.
Cashman, J. D., Lapidot, T., Wang, J. C., Doedens, M., Shultz, L. D., Lansdorp, P., et al. (1997) Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89, 4307–4316.
Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C., Bhatia, M., Lapidot, T., et al. (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2, 1329–1337.
Rebel, V. I., Dragowska, W. H., Eaves C. J., Humphries, R. K. and Lansdorp, P. M. (1994) Amplification of Sca-1+Lin-WGA+ cells in serum-free cultures containing Steel factor, interleukin-6 and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 83, 128–136.
Szilvassy, S. J., Weller, K. P., Chen, B., Tsukamoto, A., and Hoffman, R. (1996) Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice cotransplanted with highly enriched long-term repopulating hematopoietic stem cells. Blood 88, 3642–3653.
Szilvassy, S. J., Bass, M. J., Van Zant, G., and Grimes, B. (1999) Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 93, 1557–1566.
Wolf, N.S., Kone, A., Priestley, G.V., and Bartelmez, S.H. (1993) In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp. Hematol. 21, 614–622.
Morrison, S. J. and Weissman, I. L. (1994) The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661–673.
Szilvassy, S. J., Lansdorp, P. M., Humphries, R. K., Eaves, A. C., and Eaves, C. J. (1989) Isolation in a single step of a highly enriched murine hematopoietic stem cell population with competitive long-term repopulating ability. Blood 74, 930–939.
Rebel, V. I., Miller, C. L., Thornbury, G. L., Dragowska, W. H., Eaves C. J. and Lansdorp, P. M. (1996) A comparison of long-term repopulating stem cells in fetal liver and adult bone marrow from the mouse. Exp. Hematol. 24, 638–648.
Morrisson, S. J., Hemmati, H. D., Wandycz, A. M. and Weissman, I. L. (1995) The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 92, 10,302–10,306.
Holyoake, T. L., Nicolini, F., Cashman, J., and Eaves, C. J. (1997) Development and validation of an improved in vivo assay for quantitating human hematopoietic stem cells. Blood 90, 159a (Abstract).
Van der Loo, J. C. M., Hanenberg, H., Cooper, R. J., Luo, F.-Y., Lazaridis, E. N., and Williams, D. A. (1998) Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood 92, 2556–2570.
Bhatia, M., Wang, J. C., Kapp, U., Bonnet, D., and Dick, J. E. (1997) Purification of primitive human hematopoietic cells capable of repopulating immune deficient mice. Proc. Natl. Acad. Sci. USA 94, 5320–5325.
Miller, C. L., Rebel, V. I., Lemieux, M. E., Helgason, C. D., Lansdorp, P. M., and Eaves, C. J. (1996) Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Exp. Hematol. 24, 185–194.
Trevisan, M., Yan, X-Q., and Iscove, N. N. (1996) Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo. Blood 88, 4149–4158.
Bonnet, D., Bhatia, M., Wang, J. C., Kapp, U., and Dick, J. E. (1999) Cytokine treatment or accessory cells are required to initiate engraftment of purified human hematopoietic cells transplanted at limiting dose into NOD/SCID mice. Bone Marrow Transplant. 23, 203–209.
Cashman, J., Bockhold, K., Hogge, D. E., Eaves, A. C., and Eaves, C. J. (1997) Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood. Br. J. Haematol. 98, 1026–1036.
Cashman, J. D. and Eaves, C. J. (1999) Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in non-obese diabetic/severe combined immunodeficient mice. Blood 93, 481–487.
Verstegen, M.A.A., van Hennik, P.B., Terpstra, W., van den Bos, C., Wielenga, J.J., van Rooijen N., et al. (1998) Transplantion of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells. Blood 91, 1966–1976.
Drize, N. J., Keller, J. R., and Chertkov, J. L. (1996) Local clonal analysis of the hematopoietic system shows that multiple small short living clones maintain lifelong hematopoiesis in recostituted mice. Blood 88, 2927–2938.
Verlinden, S. F. F, van Es, H. H. G., and van Bekkum, D. W. (1998) Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp. Hematol. 26, 627–630.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Szilvassy, S.J., Nicolini, F.E., Eaves, C.J., Miller, C.L. (2002). Quantitation of Murine and Human Hematopoietic Stem Cells by Limiting-Dilution Analysis in Competitively Repopulated Hosts. In: Klug, C.A., Jordan, C.T. (eds) Hematopoietic Stem Cell Protocols. Methods in Molecular Medicine, vol 63. Humana Press. https://doi.org/10.1385/1-59259-140-X:167
Download citation
DOI: https://doi.org/10.1385/1-59259-140-X:167
Publisher Name: Humana Press
Print ISBN: 978-0-89603-812-7
Online ISBN: 978-1-59259-140-4
eBook Packages: Springer Protocols